Status:
WITHDRAWN
Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
Lead Sponsor:
Meir Medical Center
Conditions:
Contrast Induced Nephropathy
Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The investigators will study 2 separate groups: * Cardiology patients undergoing invasive coronary angiography +/- PCI (Percutaneous coronary intervention). * Patients undergoing CT examination with ...
Detailed Description
Impairment of renal function following exposure to intravenous radio-graphic contrast materials is the third major cause of renal hospital acquired renal dysfunction. Renal dysfunction occurs most oft...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Cardiology patients:
- Hospitalization for ACS (acute coronary syndrome) with NSTEMI or Unstable Angina
- Diabetic patients (treated with insulin or oral hypoglycemic drugs) or patients with basal serum creatinine greater than 1.3mg/dl in females and 1.5 mg/dl in male patients.
- Informed consent
- Age between 18-75
- Radiology patients:
- Radiology patients should be diabetic patients (treated with insulin or oral hypoglycemic drugs) or patients with basal serum creatinine of 1.3mg/dl in females and 1.5 mg/dl in male patients.
- Informed consent
- Age between 18-75
Exclusion
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01144091
Start Date
December 1 2012
End Date
December 1 2013
Last Update
April 8 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.